ATP-promoted amyloidosis of an amyloid β peptide
- 20 October 1997
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (15) , 3411-3414
- https://doi.org/10.1097/00001756-199710200-00043
Abstract
AMYLOIDOSIS is implicated in the aetiology of a number of disorders of human health. The factors that influence its instigation and subsequent rate of progress are the subject of a considerable research effort. The peptide fragment Aβ(25–35) is amyloidogenic and has proven to be a useful model of the processes involved in amyloidosis. It is demonstrated herein that the assembly of Aβ(25–35) into thioflavin T-reactive fibrils and their subsequent rearrangement into advanced glycation end-products is accelerated by ATP. Aluminium potentiated these effects of ATP, suggesting a possible link with the aetiology of amyloidoses in vivo.Keywords
This publication has 9 references indexed in Scilit:
- Biological availability of aluminum in commercial ATPJournal of Inorganic Biochemistry, 1996
- In vitro toxicity of β-amyloidBiochemical Journal, 1996
- Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1QJournal of Neuroscience Research, 1994
- Aluminum inhibition of hexokinase activity in vitro: A study in biological availabilityJournal of Inorganic Biochemistry, 1994
- Signalling via ATP in the nervous systemTrends in Neurosciences, 1994
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived ProteinsScience, 1981
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980